Latest On OraSure Technologies, Inc (OSUR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-17 06:43 EST | News | OraSure: Valuation Upside On The Table At 16x Forward P/E | N/A |  |
| 2023-05-16 03:11 EST | News | OraSure Technologies: As Good As It Gets | N/A | |
| 2023-05-11 09:05 EST | News | OraSure Technologies, Inc. (OSUR) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-10 19:14 EST | News | OraSure Technologies Non-GAAP EPS of $0.47 beats by $0.31, revenue of $154.96M beats by $28.39M | N/A | |
| 2023-05-10 05:58 EST | News | OraSure Technologies Q1 2023 Earnings Preview | N/A | |
| 2023-03-13 17:24 EST | News | March Madness: My Final 4 Small Cap Stocks Under $10 | N/A | |
| 2023-02-28 23:54 EST | News | OraSure: Revising To Buy Following Extensive Growth Route | N/A | |
| 2023-02-15 01:21 EST | News | OraSure Technologies Non-GAAP EPS of $0.36 beats by $0.32, revenue of $123.08M beats by $26.2M | N/A | |
| 2023-02-15 01:21 EST | News | OraSure Technologies up 15% post market on restructuring; will cut 11% of workforce | N/A | |
| 2023-02-15 01:21 EST | News | OraSure Technologies, Inc. (OSUR) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-13 23:30 EST | News | OraSure Technologies Q4 2022 Earnings Preview | N/A | |
| 2022-11-30 21:59 EST | News | OraSure: Concentration Risk From Covid Revenue, Reaffirm Hold | N/A | |
| 2022-11-23 17:45 EST | News | QuidelOrtho, OraSure among firms to win $803M defense contract for COVID tests | N/A | |
| 2022-11-09 10:21 EST | News | OraSure Technologies, Inc. (OSUR) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-08 17:11 EST | News | OraSure Technologies Non-GAAP EPS of $0.13 beats by $0.10, revenue of $116.46M beats by $24.75M | N/A | |
| 2022-11-07 23:00 EST | News | OraSure Technologies Q3 2022 Earnings Preview | N/A | |
| 2022-09-28 22:58 EST | News | OraSure wins $8.6M government contract for next-gen Ebola test | N/A | |
| 2022-09-07 05:39 EST | News | OraSure: Revenue Mix Continues To Present Risk | N/A | |
| 2022-08-29 16:41 EST | News | Biden administration ending free at-home COVID tests due to lack of funding | N/A | |
| 2022-08-10 21:45 EST | News | OraSure Technologies Q2 Non-GAAP EPS, revenue beats, new CFO appointed | N/A | |
| 2022-08-10 21:45 EST | News | OraSure adds 25% as COVID-19 testing drives Q2 earnings beat | N/A | |
| 2022-08-10 04:11 EST | News | OraSure Technologies Q2 Non-GAAP EPS, revenue beats, new CEO appointed | N/A | |
| 2022-08-10 04:11 EST | News | OraSure Technologies, Inc. (OSUR) CEO Carrie Manner on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 06:21 EST | News | OraSure Technologies Q2 2022 Earnings Preview | N/A | |
| 2022-06-11 05:54 EST | News | OraSure: Not So Sure With Softening Fundamentals, Fairly Priced At $2.54 | N/A | |
| 2022-05-25 22:09 EST | News | OraSure gains as U.S. selects COVID-19 rapid test for school distribution | N/A | |
| 2022-05-24 02:05 EST | News | OraSure Technologies gets new CEO | N/A | |
| 2022-05-11 07:38 EST | News | OraSure Technologies GAAP EPS of -$0.28, revenue of $67.71M | N/A | |
| 2022-05-11 07:37 EST | News | OraSure Technologies, Inc. (OSUR) CEO Nancy Gagliano on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-10 11:36 EST | News | OraSure Technologies Q1 2022 Earnings Preview | N/A | |
| 2022-03-31 15:20 EST | News | OraSure Technologies’ subsidiary Diversigen launches metatranscriptomic sequencing and analysis services for gut microbiome sampleshe | N/A | |
| 2022-03-23 09:33 EST | News | OraSure Technologies names Nancy Gagliano as interim CEO | N/A | |
| 2022-03-05 20:09 EST | News | OraSure Technologies: A Bet On What Used To Be | N/A | |
| 2022-02-24 17:01 EST | News | OraSure Technologies, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-24 00:04 EST | News | OraSure Technologies GAAP EPS of -$0.14 beats by $0.02, revenue of $63.57M beats by $3.58M | N/A | |
| 2022-02-24 00:04 EST | News | OraSure Technologies, Inc. (OSUR) CEO Stephen Tang on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 04:26 EST | News | OraSure Technologies Q4 2021 Earnings Preview | N/A | |
| 2022-02-11 07:29 EST | News | OraSure Technologies files for $300M mixed shelf offering | N/A | |
| 2022-01-31 21:09 EST | News | OraSure wins FDA OK for rapid COVID-19 test in children | N/A | |
| 2022-01-25 17:04 EST | News | OraSure Technologies launches oral swab in-home test for HIV in Europe | N/A | |
| 2022-01-13 19:20 EST | News | OraSure InteliSwab rapid test detects Omicron at same level as other variants | N/A | |
| 2022-01-06 01:02 EST | News | Covid test maker OraSure gains on news of exploring strategic alternatives | N/A | |
| 2021-11-04 14:18 EST | News | OraSure Technologies' (OSUR) CEO Stephen Tang on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-04 14:17 EST | News | OraSure Technologies, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-03 16:58 EST | News | OraSure Technologies EPS misses by $0.18, beats on revenue | N/A | |
| 2021-11-02 21:04 EST | News | OraSure issued amended authorization by FDA for COVID-19 rapid test | N/A | |
| 2021-11-02 21:02 EST | News | OraSure Technologies Q3 2021 Earnings Preview | N/A | |
| 2021-10-22 17:13 EST | News | The Bottom Fishing Club: OraSure Technologies | N/A | |
| 2021-10-06 14:25 EST | News | White House to make additional $1B investment in COVID-19 at-home tests | N/A | |
| 2021-09-23 09:21 EST | News | OraSure drops more than 10% most in ten months as Raymond James cuts rating | N/A | |
About OraSure Technologies, Inc (OSUR):
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, Diagnostics and Molecular Solutions. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company offers ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbime, and animal genetics markets. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.
General
- Name OraSure Technologies, Inc
- Symbol OSUR
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 570
- Last Split Factor3:1
- Last Split Date1987-04-08
- Fiscal Year EndDecember
- IPO Date1986-11-12
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.orasure.com
View More
Valuation
- Trailing PE 51.35
- Price/Sales (Trailing 12 Mt.) 3.93
- Price/Book (Most Recent Quarter) 1.81
- Enterprise Value Revenue 3.01
- Enterprise Value EBITDA 150.14
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.51
- Next Year EPS Estimate $0.63
- Next Quarter EPS Estimate $0.09
- Profit Margin -9%
- Operating Margin -3%
- Return on Assets -1%
- Return on Equity -4%
- Revenue 171.65 million
- Earnings Per Share $0.20
- Revenue Per Share $2.54
- Gross Profit 101.8 million
- Quarterly Earnings Growth 26.7%
View More
Highlights
- Market Capitalization 800.75 million
- EBITDA 3.5 million
- PE Ratio 12.36
- PEG Ratio 2.3
- Analyst Target Price $18
- Book Value Per Share $5.56
View More
Share Statistics
- Shares Outstanding 71.73 million
- Shares Float 70.79 million
- % Held by Insiders 149%
- % Held by Institutions 101%
- Shares Short 6.69 million
- Shares Short Prior Month 6.11 million
- Short Ratio 6.7
- Short % of Float 11%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta -0.15
- 52 Week High $19.75
- 52 Week Low $6.45
- 50 Day Moving Average 12.33
- 200 Day Moving Average 12.6
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
OraSure Technologies, Inc (OSUR) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
OraSure Technologies, Inc (OSUR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $N/A | $0.03 | $0.07 | -58.45% |
| 2020-09-30 | 2020-11-04 | $48.01 million | $0.01 | -$0.07 | 115.13% |
| 2020-06-30 | 2020-08-05 | $N/A | -$0.16 | -$0.10 | -68.42% |
| 2020-03-31 | 2020-05-06 | $31.6 million | -$0.12 | -$0.06 | -100% |
| 2019-12-31 | 2020-02-19 | $49.67 million | $0.04 | $0.07 | -42.86% |
| 2019-09-30 | 2019-11-06 | $35.99 million | $0.21 | $0.09 | 125.08% |
| 2019-06-30 | 2019-08-06 | $37.71 million | $0.07 | $0.02 | 200.43% |
| 2019-03-31 | 2019-05-08 | $28.92 million | -$0.05 | -$0.06 | 16.67% |
| 2018-12-31 | 2019-02-06 | $54.92 million | $0.16 | $0.11 | 45.45% |
| 2018-09-30 | 2018-11-07 | $44.53 million | $0.13 | $0.11 | 18.18% |
| 2018-06-30 | 2018-08-08 | $40.74 million | $0.07 | $0.04 | 86.67% |
| 2018-03-31 | 2018-05-02 | $39.86 million | -$0.03 | -$0.06 | 50% |
| 2017-12-31 | 2018-02-07 | $52.03 million | $0.12 | $0.11 | 11.11% |
| 2017-09-30 | 2017-11-01 | $42.31 million | $0.09 | $0.09 | -2.17% |
| 2017-06-30 | 2017-08-02 | $40.18 million | $0.09 | $0.07 | 25% |
| 2017-03-31 | 2017-05-03 | $32.55 million | $0.21 | $0.18 | 18.85% |
| 2016-12-31 | 2017-02-08 | $35.5 million | $0.13 | $0.06 | 129.28% |
| 2016-09-30 | 2016-11-02 | $32.25 million | $0.11 | $0.07 | 48.65% |
| 2016-06-30 | 2016-08-03 | $31.36 million | $0.07 | $0.05 | 49.89% |
| 2016-03-31 | 2016-05-04 | $29.09 million | $0.04 | $0.02 | 139.52% |
| 2015-12-31 | 2016-02-03 | $32.38 million | $0.08 | $0.03 | 182.69% |
| 2015-09-30 | 2015-11-04 | $29.86 million | $0.03 | -$0.01 | 400% |
| 2015-06-30 | 2015-08-05 | $30.39 million | $0.03 | $0.01 | 200% |
| 2015-03-31 | 2015-05-06 | $27.09 million | $0.00 | -$0.01 | 120% |
| 2014-12-31 | 2015-02-04 | $28.68 million | -$0.05 | -$0.04 | -25% |
| 2014-09-30 | 2014-11-05 | $27.85 million | $0.02 | -$0.05 | 140% |
| 2014-06-30 | 2014-08-06 | $26.4 million | -$0.05 | -$0.04 | -25% |
| 2014-03-31 | 2014-05-07 | $23.54 million | -$0.10 | -$0.13 | 23.08% |
| 2013-12-31 | 2014-02-05 | $26.27 million | -$0.04 | -$0.08 | 50% |
| 2013-09-30 | 2013-11-06 | $24.67 million | -$0.03 | -$0.10 | 70% |
| 2013-06-30 | 2013-08-07 | $24.34 million | -$0.10 | -$0.16 | 37.5% |
| 2013-03-31 | 2013-05-08 | $21.16 million | -$0.06 | -$0.18 | 66.67% |
| 2012-12-31 | 2013-02-06 | $22.15 million | -$0.11 | -$0.14 | 21.43% |
| 2012-09-30 | 2012-11-07 | $22.12 million | -$0.04 | -$0.08 | 50% |
| 2012-06-30 | 2012-08-07 | $22.62 million | -$0.07 | -$0.09 | 22.22% |
| 2012-03-31 | 2012-05-02 | $20.94 million | -$0.08 | -$0.08 | 0% |
| 2011-12-31 | 2012-02-08 | $23.69 million | $0.02 | -$0.05 | 140% |
| 2011-09-30 | 2011-11-02 | $21.71 million | -$0.03 | -$0.07 | 57.14% |
| 2011-06-30 | 2011-08-03 | $19.06 million | -$0.05 | -$0.07 | 28.57% |
| 2011-03-31 | 2011-05-04 | $17.41 million | -$0.06 | -$0.08 | 25% |
| 2010-12-31 | 2011-02-09 | $18.82 million | -$0.02 | -$0.08 | 75% |
| 2010-09-30 | 2010-11-09 | $19.03 million | $0.01 | -$0.04 | 125% |
| 2010-06-30 | 2010-08-04 | $19.22 million | -$0.01 | -$0.08 | 87.5% |
| 2010-03-31 | 2010-05-05 | $17.95 million | -$0.05 | -$0.06 | 16.67% |
| 2009-12-31 | 2010-02-10 | $20.89 million | -$0.03 | -$0.08 | 62.5% |
| 2009-09-30 | 2009-11-04 | $21.61 million | $0.04 | -$0.05 | 180% |
| 2009-06-30 | 2009-08-05 | $17.27 million | -$0.05 | -$0.06 | 16.67% |
| 2009-03-31 | 2009-05-06 | $17.26 million | -$0.04 | -$0.07 | 42.86% |
| 2008-12-31 | 2009-02-11 | $17.21 million | -$0.64 | -$0.09 | -611.11% |
| 2008-09-30 | 2008-11-05 | $16.86 million | -$0.04 | -$0.09 | 55.56% |
| 2008-06-30 | 2008-08-05 | $18.95 million | -$0.05 | -$0.07 | 28.57% |
| 2008-03-31 | 2008-05-06 | $18.09 million | $0.04 | $0.03 | 33.33% |
| 2007-12-31 | 2008-02-12 | $19.81 million | $0.00 | ||
| 2007-09-30 | 2007-10-30 | $21.42 million | $0.00 | $0.01 | -99% |
| 2007-06-30 | 2007-07-31 | $21.35 million | $0.02 | $0.01 | 100% |
| 2007-03-31 | 2007-05-08 | $20.11 million | $0.03 | $0.02 | 50% |
| 2006-12-31 | 2007-02-13 | $17.73 million | $0.02 | $0.02 | 0% |
| 2006-09-30 | 2006-11-01 | $17.64 million | $0.05 | $0.01 | 400% |
| 2006-06-30 | 2006-08-08 | $17.57 million | $0.03 | $0.02 | 50% |
| 2006-03-31 | 2006-05-02 | $15.22 million | $0.02 | $0.02 | 0% |
| 2005-12-31 | 2006-02-09 | $18.03 million | $0.05 | $0.05 | 0% |
| 2005-09-30 | 2005-11-09 | $18.08 million | $0.08 | $0.05 | 60% |
| 2005-06-30 | 2005-08-02 | $17.43 million | $0.06 | $0.02 | 200% |
| 2005-03-31 | 2005-05-03 | $15.83 million | $0.03 | ||
| 2004-12-31 | 2005-02-10 | $14.21 million | -$0.01 | -$0.02 | 50% |
| 2004-09-30 | 2004-11-02 | $14.18 million | -$0.01 | -$0.01 | 0% |
| 2004-06-30 | 2004-08-03 | $13.21 million | $0.00 | -$0.01 | 131% |
| 2004-03-31 | 2004-04-27 | $12.41 million | $-0.00 | -$0.01 | 63% |
| 2003-12-31 | 2004-02-10 | $11.88 million | $0.01 | $0.01 | 0% |
| 2003-09-30 | 2003-10-28 | $10.33 million | $0.00 | -$0.01 | 113% |
| 2003-06-30 | 2003-07-29 | $9.63 million | -$0.01 | -$0.03 | 66.67% |
| 2003-03-31 | 2003-04-29 | $8.61 million | -$0.03 | -$0.04 | 25% |
| 2002-12-31 | 2003-02-05 | $8.25 million | $-0.00 | -$0.01 | 78% |
| 2002-09-30 | 2002-10-28 | $8.11 million | -$0.01 | -$0.02 | 50% |
| 2002-06-30 | 2002-07-29 | $7.93 million | -$0.03 | -$0.04 | 25% |
| 2002-03-31 | 2002-04-30 | $7.73 million | -$0.04 | -$0.05 | 20% |
| 2001-12-31 | 2002-02-15 | $8.06 million | -$0.06 | -$0.03 | -100% |
| 2001-09-30 | 2001-10-24 | $8.6 million | $0.00 | $0.02 | -98% |
| 2001-06-30 | 2001-07-27 | $8.51 million | -$0.01 | ||
| 2001-03-31 | 2001-05-01 | $7.4 million | -$0.02 | -$0.01 | -100% |
| 2000-12-31 | 2001-01-01 | $7.79 million | -$0.05 | -$0.02 | -150% |
| 2000-09-30 | 2000-10-01 | $7.22 million | -$0.06 | $0.01 | -700% |
| 2000-06-30 | 2000-07-31 | $10.7 million | $0.01 | $0.01 | 0% |
| 2000-03-31 | 2000-04-25 | $3.08 million | -$0.06 |
OraSure Technologies, Inc (OSUR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
OraSure Technologies, Inc (OSUR) Chart:
OraSure Technologies, Inc (OSUR) News:
Below you will find a list of latest news for OraSure Technologies, Inc (OSUR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
OraSure Technologies, Inc (OSUR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-04-17 | 2.5 | 1.2 | CALL | 0 | 68 | 444.64 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0.1 | CALL | 0 | 700 | 198.95 | FALSE | 0 | 0 |
| 2025-04-17 | 7.5 | 0.11 | CALL | 0 | 102 | 371.98 | FALSE | 0 | 0 |
| 2025-04-17 | 2.5 | 0.2 | PUT | 0 | 1 | 232.67 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 1.95 | PUT | 20 | 22 | 360.48 | TRUE | 1.95 | 0 |
| 2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 488.81 | TRUE | 0 | 0 |
| 2025-05-16 | 2.5 | 0 | CALL | 0 | 0 | 132.54 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 0.24 | CALL | 0 | 3 | 120.85 | FALSE | 0 | 0 |
| 2025-05-16 | 7.5 | 0 | CALL | 0 | 0 | 378.98 | FALSE | 0 | 0 |
| 2025-05-16 | 2.5 | 0.05 | PUT | 0 | 1 | 142.19 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0 | PUT | 0 | 0 | 236.87 | TRUE | 0 | 0 |
| 2025-05-16 | 7.5 | 0 | PUT | 0 | 0 | 308.16 | TRUE | 0 | 0 |
| 2025-07-18 | 2.5 | 1.18 | CALL | 0 | 274 | 172.79 | TRUE | 0 | 0 |
| 2025-07-18 | 5 | 0.05 | CALL | 0 | 295 | 129.78 | FALSE | 0 | 0 |
| 2025-07-18 | 7.5 | 0.07 | CALL | 0 | 1 | 162.79 | FALSE | 0 | 0 |
| 2025-07-18 | 2.5 | 0.18 | PUT | 0 | 38 | 35.24 | FALSE | 0 | 0 |
| 2025-07-18 | 5 | 1.8 | PUT | 0 | 58 | 0 | TRUE | 0 | 0 |
| 2025-07-18 | 7.5 | 4.5 | PUT | 0 | 1 | 242.16 | TRUE | 0 | 0 |
| 2025-10-17 | 2.5 | 1.04 | CALL | 0 | 181 | 138.66 | TRUE | 0 | 0 |
| 2025-10-17 | 5 | 0.11 | CALL | 0 | 45 | 114.78 | FALSE | 0 | 0 |
| 2025-10-17 | 7.5 | 0.02 | CALL | 0 | 140 | 296.59 | FALSE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | PUT | 0 | 0 | 95.13 | FALSE | 0 | 0 |
| 2025-10-17 | 5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2025-10-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
Latest OSUR Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 57 | $2.72 |
| Jun 13, 2022 7:59 PM EST | 59 | $2.72 |
| Jun 13, 2022 7:59 PM EST | 29 | $2.72 |
| Jun 13, 2022 7:59 PM EST | 48 | $2.72 |
| Jun 13, 2022 7:59 PM EST | 100 | $2.715 |
OraSure Technologies, Inc (OSUR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001512/0001593968-20-001512-index.htm |
| 2019-02-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1116463/000000000019001045/0000000000-19-001045-index.htm |
| 2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000021545719002171/0000215457-19-002171-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000083423720002125/0000834237-20-002125-index.htm |
| 2018-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000089924318023482/0000899243-18-023482-index.htm |
| 2018-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000089924318027364/0000899243-18-027364-index.htm |
| 2018-11-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000089924318028043/0000899243-18-028043-index.htm |
| 2018-11-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000089924318029875/0000899243-18-029875-index.htm |
| 2018-12-06 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000089924318030262/0000899243-18-030262-index.htm |
| 2018-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000090221918000537/0000902219-18-000537-index.htm |
| 2020-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000090221920000196/0000902219-20-000196-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000093247119005711/0000932471-19-005711-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000103738919000215/0001037389-19-000215-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000103738920000236/0001037389-20-000236-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000108514619000875/0001085146-19-000875-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000110465919008442/0001104659-19-008442-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000110465920018709/0001104659-20-018709-index.htm |
| 2020-02-20 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000110465920023302/0001104659-20-023302-index.htm |
| 2018-12-18 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1116463/000119312518352126/0001193125-18-352126-index.htm |
| 2019-02-11 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1116463/000119312519033951/0001193125-19-033951-index.htm |
| 2019-02-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1116463/000119312519033960/0001193125-19-033960-index.htm |
| 2019-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000119312519143856/0001193125-19-143856-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000119312520157457/0001193125-20-157457-index.htm |
| 2020-06-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1116463/000119312520157788/0001193125-20-157788-index.htm |
| 2020-06-03 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1116463/000119312520159696/0001193125-20-159696-index.htm |
| 2020-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000119312520160688/0001193125-20-160688-index.htm |
| 2020-08-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000119380520000992/0001193805-20-000992-index.htm |
| 2018-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000020/0001209784-18-000020-index.htm |
| 2018-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000021/0001209784-18-000021-index.htm |
| 2018-05-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000022/0001209784-18-000022-index.htm |
| 2018-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000023/0001209784-18-000023-index.htm |
| 2018-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000024/0001209784-18-000024-index.htm |
| 2018-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000025/0001209784-18-000025-index.htm |
| 2018-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000026/0001209784-18-000026-index.htm |
| 2018-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000027/0001209784-18-000027-index.htm |
| 2018-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000028/0001209784-18-000028-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000029/0001209784-18-000029-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1116463/000125889720001208/0001258897-20-001208-index.htm |
| 2018-05-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018013224/0001564590-18-013224-index.htm |
| 2018-06-07 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1116463/000156459018015239/0001564590-18-015239-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018020563/0001564590-18-020563-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459018021034/0001564590-18-021034-index.htm |
| 2018-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018021976/0001564590-18-021976-index.htm |
| 2018-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018022262/0001564590-18-022262-index.htm |
| 2018-10-04 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018023981/0001564590-18-023981-index.htm |
| 2018-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018025429/0001564590-18-025429-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018028110/0001564590-18-028110-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459018028291/0001564590-18-028291-index.htm |
| 2018-12-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459018031460/0001564590-18-031460-index.htm |
| 2019-01-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019000136/0001564590-19-000136-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019002161/0001564590-19-002161-index.htm |
| 2019-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019003012/0001564590-19-003012-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1116463/000156459019005491/0001564590-19-005491-index.htm |
| 2019-03-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019010163/0001564590-19-010163-index.htm |
| 2019-04-10 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1116463/000156459019011253/0001564590-19-011253-index.htm |
| 2019-04-10 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1116463/000156459019011255/0001564590-19-011255-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019017315/0001564590-19-017315-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459019018010/0001564590-19-018010-index.htm |
| 2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019020327/0001564590-19-020327-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019029431/0001564590-19-029431-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459019030124/0001564590-19-030124-index.htm |
| 2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019031997/0001564590-19-031997-index.htm |
| 2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019032527/0001564590-19-032527-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459019041107/0001564590-19-041107-index.htm |
| 2019-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459019042250/0001564590-19-042250-index.htm |
| 2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020005314/0001564590-20-005314-index.htm |
| 2020-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020005778/0001564590-20-005778-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1116463/000156459020008195/0001564590-20-008195-index.htm |
| 2020-03-05 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1116463/000156459020009000/0001564590-20-009000-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020011875/0001564590-20-011875-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020015369/0001564590-20-015369-index.htm |
| 2020-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020015801/0001564590-20-015801-index.htm |
| 2020-04-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1116463/000156459020016101/0001564590-20-016101-index.htm |
| 2020-04-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1116463/000156459020016104/0001564590-20-016104-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020020988/0001564590-20-020988-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020022023/0001564590-20-022023-index.htm |
| 2020-05-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459020024205/0001564590-20-024205-index.htm |
| 2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020026167/0001564590-20-026167-index.htm |
| 2020-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020027454/0001564590-20-027454-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020036891/0001564590-20-036891-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459020037770/0001564590-20-037770-index.htm |
| 2020-08-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020041206/0001564590-20-041206-index.htm |
| 2020-08-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1116463/000156459020041352/0001564590-20-041352-index.htm |
| 2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020042041/0001564590-20-042041-index.htm |
| 2020-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020050555/0001564590-20-050555-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1116463/000156459020051334/0001564590-20-051334-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1116463/000156459020051433/0001564590-20-051433-index.htm |
| 2019-01-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000088/0001593968-19-000088-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000346/0001593968-19-000346-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000347/0001593968-19-000347-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000348/0001593968-19-000348-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000349/0001593968-19-000349-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000350/0001593968-19-000350-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000351/0001593968-19-000351-index.htm |
| 2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000353/0001593968-19-000353-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000917/0001593968-19-000917-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000974/0001593968-19-000974-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001053/0001593968-19-001053-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001054/0001593968-19-001054-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001055/0001593968-19-001055-index.htm |
| 2019-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001056/0001593968-19-001056-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001062/0001593968-19-001062-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001096/0001593968-19-001096-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001097/0001593968-19-001097-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001098/0001593968-19-001098-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001156/0001593968-19-001156-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001162/0001593968-19-001162-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001163/0001593968-19-001163-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001164/0001593968-19-001164-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001165/0001593968-19-001165-index.htm |
| 2019-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001167/0001593968-19-001167-index.htm |
| 2019-08-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001730/0001593968-19-001730-index.htm |
| 2019-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001731/0001593968-19-001731-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000313/0001593968-20-000313-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000314/0001593968-20-000314-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000315/0001593968-20-000315-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000316/0001593968-20-000316-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000317/0001593968-20-000317-index.htm |
| 2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000318/0001593968-20-000318-index.htm |
| 2020-04-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000996/0001593968-20-000996-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000997/0001593968-20-000997-index.htm |
| 2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001000/0001593968-20-001000-index.htm |
| 2020-05-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001143/0001593968-20-001143-index.htm |
| 2020-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001156/0001593968-20-001156-index.htm |
| 2020-05-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001173/0001593968-20-001173-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001210/0001593968-20-001210-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001212/0001593968-20-001212-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001213/0001593968-20-001213-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001214/0001593968-20-001214-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001215/0001593968-20-001215-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001216/0001593968-20-001216-index.htm |
| 2020-05-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001217/0001593968-20-001217-index.htm |
| 2020-06-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001321/0001593968-20-001321-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001322/0001593968-20-001322-index.htm |
| 2020-06-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001512/0001593968-20-001512-index.htm |
| 2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001944/0001593968-20-001944-index.htm |
| 2019-02-13 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1116463/999999999519000211/9999999995-19-000211-index.htm |
OraSure Technologies, Inc (OSUR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of OraSure Technologies, Inc (OSUR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 149%Institutional Ownership: 10100%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-02-01 | Kathleen Gallagher Weber | EVP & BU Lead - Molecular | Buy | 10,238.00 | 7.17 | 73,355.27 | 102,229.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000318/0001593968-20-000318-index.htm |
| 2020-02-01 | Kathleen Gallagher Weber | EVP & BU Lead - Molecular | Buy | 10,238.00 | 7.17 | 73,355.27 | 109,444.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000318/0001593968-20-000318-index.htm |
| 2019-02-01 | STEPHEN S PHD TANG | President and CEO | Buy | 47,872.00 | 118,960.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000347/0001593968-19-000347-index.htm | ||
| 2019-04-01 | STEPHEN S PHD TANG | President and CEO | Sell | 16,667.00 | 11.10 | 185,015.37 | 118,960.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000917/0001593968-19-000917-index.htm |
| 2019-05-14 | STEPHEN S PHD TANG | President and CEO | Buy | 1,000.00 | 8.56 | 8,560.00 | 119,960.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001098/0001593968-19-001098-index.htm |
| 2020-02-01 | JACK E JERRETT | SVP & General Counsel | Buy | 35,813.00 | 7.17 | 256,600.15 | 120,837.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000314/0001593968-20-000314-index.htm |
| 2018-05-08 | RONNY B LANCASTER | Director | Buy | 6,144.00 | 12,439.00 | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000020/0001209784-18-000020-index.htm | ||
| 2020-02-01 | JACK E JERRETT | SVP & General Counsel | Buy | 11,193.00 | 7.17 | 80,197.85 | 132,030.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000314/0001593968-20-000314-index.htm |
| 2019-08-12 | James A Datin | Director | Buy | 13,432.00 | 7.45 | 100,001.24 | 13,432.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001731/0001593968-19-001731-index.htm |
| 2019-04-01 | STEPHEN S PHD TANG | President and CEO | Buy | 16,667.00 | 8.33 | 138,752.78 | 135,627.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000917/0001593968-19-000917-index.htm |
| 2020-02-01 | JACK E JERRETT | SVP & General Counsel | Buy | 11,195.00 | 7.17 | 80,212.18 | 138,375.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000314/0001593968-20-000314-index.htm |
| 2020-05-11 | Lisa Nibauer | EVP & BU Lead - Infectious | Buy | 14,071.00 | 17.77 | 250,006.49 | 14,071.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001156/0001593968-20-001156-index.htm |
| 2020-02-01 | Michele Marie Miller | VP, Finance and Controller | Buy | 7,545.00 | 7.17 | 54,059.93 | 14,861.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000316/0001593968-20-000316-index.htm |
| 2020-05-18 | David Shulkin | Director | Buy | 6,577.00 | 15.97 | 105,001.81 | 15,542.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001215/0001593968-20-001215-index.htm |
| 2020-04-08 | James A Datin | Director | Buy | 2,145.00 | 10.61 | 22,747.73 | 15,577.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001000/0001593968-20-001000-index.htm |
| 2019-02-01 | II Anthony Zezzo | EVP & BU Lead - Infectious | Buy | 19,667.00 | 157,774.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000353/0001593968-19-000353-index.htm | ||
| 2020-06-23 | James A Datin | Director | Buy | 1,667.00 | 9.74 | 16,244.08 | 16,658.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001512/0001593968-20-001512-index.htm |
| 2019-05-21 | ARADHANA SARIN | Director | Buy | 12,382.00 | 8.48 | 104,999.36 | 16,865.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001162/0001593968-19-001162-index.htm |
| 2020-09-25 | James A Datin | Director | Buy | 1,492.00 | 10.89 | 16,247.88 | 17,695.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001944/0001593968-20-001944-index.htm |
| 2019-02-01 | II Anthony Zezzo | EVP & BU Lead - Infectious | Buy | 24,135.00 | 12.98 | 313,332.64 | 181,909.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000353/0001593968-19-000353-index.htm |
| 2019-02-01 | II Anthony Zezzo | EVP & BU Lead - Infectious | Buy | 24,135.00 | 12.98 | 313,332.64 | 194,827.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000353/0001593968-19-000353-index.htm |
| 2020-02-01 | STEPHEN S PHD TANG | President and CEO | Buy | 84,997.00 | 7.17 | 609,003.51 | 199,763.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000313/0001593968-20-000313-index.htm |
| 2020-02-01 | II Anthony Zezzo | EVP & BU Lead - Infectious | Buy | 34,698.00 | 7.17 | 248,611.17 | 209,753.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000317/0001593968-20-000317-index.htm |
| 2019-05-21 | RONNY B LANCASTER | Director | Buy | 12,382.00 | 8.48 | 104,999.36 | 21,029.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001163/0001593968-19-001163-index.htm |
| 2020-05-18 | James A Datin | Director | Buy | 6,577.00 | 15.97 | 105,001.81 | 21,568.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001214/0001593968-20-001214-index.htm |
| 2020-02-01 | II Anthony Zezzo | EVP & BU Lead - Infectious | Buy | 16,560.00 | 7.17 | 118,652.40 | 226,313.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000317/0001593968-20-000317-index.htm |
| 2019-05-21 | Mara G. Aspinall | Director | Buy | 12,382.00 | 8.48 | 104,999.36 | 23,526.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001164/0001593968-19-001164-index.htm |
| 2020-02-01 | II Anthony Zezzo | EVP & BU Lead - Infectious | Buy | 16,560.00 | 7.17 | 118,652.40 | 235,398.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000317/0001593968-20-000317-index.htm |
| 2020-05-18 | RONNY B LANCASTER | Director | Buy | 6,577.00 | 15.97 | 105,001.81 | 23,830.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001210/0001593968-20-001210-index.htm |
| 2020-05-18 | Mara G. Aspinall | Director | Buy | 6,577.00 | 15.97 | 105,001.81 | 26,760.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001216/0001593968-20-001216-index.htm |
| 2019-05-21 | EAMONN P HOBBS | Director | Buy | 12,382.00 | 8.48 | 104,999.36 | 30,502.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001156/0001593968-19-001156-index.htm |
| 2019-02-01 | MICHAEL REED | SVP R&D and CSO | Buy | 6,470.00 | 34,150.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000349/0001593968-19-000349-index.htm | ||
| 2019-02-01 | Kathleen Gallagher Weber | EVP & BU Lead - Molecular | Buy | 13,028.00 | 34,197.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000351/0001593968-19-000351-index.htm | ||
| 2020-05-18 | EAMONN P HOBBS | Director | Buy | 6,577.00 | 15.97 | 105,001.81 | 34,355.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001217/0001593968-20-001217-index.htm |
| 2019-02-01 | Roberto Cuca | CFO | Buy | 24,614.00 | 38,934.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000346/0001593968-19-000346-index.htm | ||
| 2019-05-10 | Roberto Cuca | CFO | Buy | 6,393.00 | 9.04 | 57,792.72 | 43,968.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001096/0001593968-19-001096-index.htm |
| 2019-05-10 | Roberto Cuca | CFO | Buy | 1,300.00 | 9.01 | 11,713.00 | 45,268.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001096/0001593968-19-001096-index.htm |
| 2019-05-10 | Roberto Cuca | CFO | Buy | 1,200.00 | 9.02 | 10,824.00 | 46,468.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001096/0001593968-19-001096-index.htm |
| 2019-05-10 | Roberto Cuca | CFO | Buy | 700.00 | 9.03 | 6,321.00 | 47,168.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001096/0001593968-19-001096-index.htm |
| 2019-05-10 | Roberto Cuca | CFO | Buy | 407.00 | 9.00 | 3,663.00 | 47,575.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001096/0001593968-19-001096-index.htm |
| 2019-02-01 | MICHAEL REED | SVP R&D and CSO | Buy | 14,510.00 | 12.98 | 188,376.08 | 48,660.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000349/0001593968-19-000349-index.htm |
| 2018-08-27 | Charles W Patrick | Director | Sell | 8,000.00 | 16.29 | 130,320.00 | 54,298.00 | https://www.sec.gov/Archives/edgar/data/1116463/000089924318023482/0000899243-18-023482-index.htm |
| 2019-02-01 | Kathleen Gallagher Weber | EVP & BU Lead - Molecular | Buy | 20,400.00 | 12.98 | 264,843.00 | 54,597.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000351/0001593968-19-000351-index.htm |
| 2018-10-22 | MARK L KUNA | Officer | Buy | 15,048.00 | 14.81 | 222,860.88 | 56,822.00 | https://www.sec.gov/Archives/edgar/data/1116463/000089924318027364/0000899243-18-027364-index.htm |
| 2019-02-01 | MICHAEL REED | SVP R&D and CSO | Buy | 14,508.00 | 12.98 | 188,350.11 | 57,585.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000349/0001593968-19-000349-index.htm |
| 2018-05-08 | ARADHANA SARIN | Director | Buy | 6,144.00 | 6,144.00 | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000022/0001209784-18-000022-index.htm | ||
| 2019-02-01 | JACK E JERRETT | SVP & General Counsel | Buy | 18,524.00 | 61,493.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000350/0001593968-19-000350-index.htm | ||
| 2019-05-21 | Charles W Patrick | Director | Buy | 12,382.00 | 8.48 | 104,999.36 | 62,436.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001165/0001593968-19-001165-index.htm |
| 2019-05-21 | Michael Celano | Director | Buy | 15,330.00 | 8.48 | 129,998.40 | 62,642.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001167/0001593968-19-001167-index.htm |
| 2018-10-22 | MARK L KUNA | Officer | Buy | 4,388.00 | 14.81 | 64,986.28 | 63,173.00 | https://www.sec.gov/Archives/edgar/data/1116463/000089924318027364/0000899243-18-027364-index.htm |
| 2018-05-08 | Charles W Patrick | Director | Buy | 6,144.00 | 64,326.00 | https://www.sec.gov/Archives/edgar/data/1116463/000120978418000021/0001209784-18-000021-index.htm | ||
| 2018-10-22 | MARK L KUNA | Officer | Buy | 15,047.00 | 14.81 | 222,846.07 | 65,327.00 | https://www.sec.gov/Archives/edgar/data/1116463/000089924318027364/0000899243-18-027364-index.htm |
| 2020-05-18 | Michael Celano | Director | Buy | 8,143.00 | 15.97 | 130,003.00 | 66,942.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001212/0001593968-20-001212-index.htm |
| 2018-10-22 | MARK L KUNA | Officer | Buy | 1,716.00 | 14.81 | 25,413.96 | 67,943.00 | https://www.sec.gov/Archives/edgar/data/1116463/000089924318027364/0000899243-18-027364-index.htm |
| 2018-10-22 | MARK L KUNA | Officer | Buy | 1,716.00 | 14.81 | 25,413.96 | 68,913.00 | https://www.sec.gov/Archives/edgar/data/1116463/000089924318027364/0000899243-18-027364-index.htm |
| 2019-02-01 | Kathleen Gallagher Weber | EVP & BU Lead - Molecular | Buy | 20,400.00 | 12.98 | 264,843.00 | 69,188.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000351/0001593968-19-000351-index.htm |
| 2018-10-22 | MARK L KUNA | Officer | Buy | 8,777.00 | 14.81 | 129,987.37 | 70,043.00 | https://www.sec.gov/Archives/edgar/data/1116463/000089924318027364/0000899243-18-027364-index.htm |
| 2020-06-01 | Lelio Marmora | Director | Buy | 7,015.00 | 14.26 | 99,998.83 | 7,015.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820001322/0001593968-20-001322-index.htm |
| 2019-02-01 | JACK E JERRETT | SVP & General Counsel | Buy | 18,038.00 | 12.98 | 234,178.34 | 79,531.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000350/0001593968-19-000350-index.htm |
| 2019-02-01 | Michele Marie Miller | VP, Finance and Controller | Buy | 3,813.00 | 8,071.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000348/0001593968-19-000348-index.htm | ||
| 2019-05-13 | JACK E JERRETT | SVP & General Counsel | Buy | 1,313.00 | 8.54 | 11,213.02 | 83,198.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001097/0001593968-19-001097-index.htm |
| 2020-04-06 | David Shulkin | Director | Buy | 8,965.00 | 11.16 | 100,004.58 | 8,965.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000997/0001593968-20-000997-index.htm |
| 2019-02-01 | JACK E JERRETT | SVP & General Counsel | Buy | 18,038.00 | 12.98 | 234,178.34 | 89,727.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819000350/0001593968-19-000350-index.htm |
| 2019-05-13 | JACK E JERRETT | SVP & General Counsel | Buy | 8,687.00 | 8.55 | 74,273.85 | 91,885.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396819001097/0001593968-19-001097-index.htm |
| 2020-02-01 | Kathleen Gallagher Weber | EVP & BU Lead - Molecular | Buy | 32,516.00 | 7.17 | 232,977.14 | 91,991.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000318/0001593968-20-000318-index.htm |
| 2020-02-01 | Roberto Cuca | CFO | Buy | 47,908.00 | 7.17 | 343,260.82 | 92,712.00 | https://www.sec.gov/Archives/edgar/data/1116463/000159396820000315/0001593968-20-000315-index.htm |